Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 78 for “"EphA2"”.

  1. The Influence of Membrane Lipids and Novel EphA2 Ligands on EphA2 Structure and Function

    … capture the structural dynamics of the RTK EphA2 and characterize the factors that regulate these dynamics. Furthermore, we investigate the activity of EphA2-interacting partners as a function of the factors regulating EphA2’s structural changes. We find that cholesterol content inhibits …

    utk-theses Repository record for The Influence of Membrane Lipids and Novel EphA2 Ligands on EphA2 Structure and Function (opens in a new tab)

  2. Role and Regulation of Epha2 In Pancreatic Cancer

    … was to investigate the role and regulation of EphA2, a receptor tyrosine kinase expressed in PDAC, to further understand this disease and identify new therapeutic targets. The role of EphA2 was determined in PDAC by siRNA mediated silencing. In combination with gemcitabine, silencing of EphA2 …

    uthsc Repository record for Role and Regulation of Epha2 In Pancreatic Cancer (opens in a new tab)

  3. Combination Therapies to Target EphA2 and EGFR Expressing Tumors.

    … of the RTK family, the ephrin receptor type A2 (EphA2) and the epidermal growth factor receptor (EGFR) both in humans and dogs. The emergence of therapy resistance and metastasis are amongst the most aggressive features of cancer, which can be ascribed to a particular population of tumor cells, …

    sask Repository record for Combination Therapies to Target EphA2 and EGFR Expressing Tumors. (opens in a new tab)

  4. Characterizing transmembrane-lipid interactions of EphA2 and pH responsive peptides

    … the TM region of a receptor tyrosine kinase, EphA2. EphA2 engages in both tumorigenic (ligand-independent) and anti-tumorigenic (ligand-dependent) signaling making it an attractive drug target. From TYPE7 we learned that the activity of EphA2 could be modulated by interactions with a TM …

    utk-theses Repository record for Characterizing transmembrane-lipid interactions of EphA2 and pH responsive peptides (opens in a new tab)

  5. EphA2 Oligomerization Studies In The Plasma Membrane: Implications For Signaling

    … of binding with exquisite specificity to the RTK EphA2 and promoting activity at levels comparable to its physiological ligand, Ephrin-A1. Using a quantitative FRET approach, these peptides were found to induce the formation of clusters when bound to the receptor, a behavior seen in a …

    jhu Repository record for EphA2 Oligomerization Studies In The Plasma Membrane: Implications For Signaling (opens in a new tab)

  6. Metastatic MAT Phenotype Driven by Noncanonical EphA2 Signaling in Melanoma

    … we identified noncanonical ephrin receptor (Eph) EphA2 signaling as a driver of the resistance-associated metastatic state. We used mass spectrometry‒based proteomic and phenotypic assays to demonstrate that the expression of active noncanonical EphA2-S897E in melanoma cells led to a …

    usf Repository record for Metastatic MAT Phenotype Driven by Noncanonical EphA2 Signaling in Melanoma (opens in a new tab)

  7. Functional and mechanistic characterization of EphA2 in human and canine melanoma

    … to its role in tumor progression. In particular, EphA2 has emerged as a promising target in human cancers; however, its role in melanoma, especially in canine models, remains incompletely understood. This thesis addressed this gap using a comparative oncology approach, combining the development of …

    sask Repository record for Functional and mechanistic characterization of EphA2 in human and canine melanoma (opens in a new tab)

  8. Investigating The Effects of Silencing Epha2 In Metastatic Breast Cancer Cells

    EphA2, also known as ECK (epithelial cell kinase), is a transmembrane receptor tyrosine kinase that is commonly over-expressed in cancers such as those of the prostate, colon, lung, and breast. For breast cancers, EphA2 overexpression is most prominent in the ER-negative subtype, and is associated …

    uthsc Repository record for Investigating The Effects of Silencing Epha2 In Metastatic Breast Cancer Cells (opens in a new tab)

  9. Effects of EphA2 Receptor Activation on Behaviour and Brain Systems Activity

    … poorly understood. Recently, we demonstrated the EphA2 receptor in the prefrontal cortex (PFC) may play a key role underlying female stress susceptibility. This thesis investigates the effects of brain-wide EphA2 receptor activation in rats to elucidate sex-specific roles of the receptor in …

    guelph Repository record for Effects of EphA2 Receptor Activation on Behaviour and Brain Systems Activity (opens in a new tab)

  10. Targeting EPHA2 in Hepatocellular Carcinoma: Uncovering Its Therapeutic Potential and Beyond

    … molecular-targeted therapies. Here, we identify EphA2 receptor tyrosine kinase as a clinically relevant target for HCC. EphA2 expression and signaling is enriched in human HCC and associates with poor prognosis. Loss of EphA2 suppressed the initiation and growth of HCC in vitro and in vivo. …

    loyola-thes Repository record for Targeting EPHA2 in Hepatocellular Carcinoma: Uncovering Its Therapeutic Potential and Beyond (opens in a new tab)

  11. A comparative study of the role EphA2 performs in canine and human osteosarcoma

    … research with benefits to both parties. The EphA2 receptor, a member of the Eph family of receptor tyrosine kinases, has been shown to be upregulated in different human malignancies and its function has been linked to poor prognosis and tumor aggressive properties. Accordingly, this receptor …

    sask Repository record for A comparative study of the role EphA2 performs in canine and human osteosarcoma (opens in a new tab)

  12. The role of human Ephrin receptor tyrosine kinase A2 (EphA2) in Chlamydia trachomatis infection

    … Thomas Meyer). Interestingly, EphrinA2 receptor (EphA2), a cell surface tyrosine kinase receptor, implicated in many cancers, was identified as one of the potential candidates. Due to the presence of EphA2 in the Ctr inclusion proteome data, I investigated the role of EphA2 in Ctr infection. EphA2 …

    wurz-thes Repository record for The role of human Ephrin receptor tyrosine kinase A2 (EphA2) in Chlamydia trachomatis infection (opens in a new tab)

  13. Expression patterns of EphA2 tyrosine kinase receptor in human digestive system organs and tumors

    … and diagnosis. The ephrin type-A receptor 2 (EphA2) plays important roles both in tumorigenesis and in angiogenesis. This receptor has attracted considerable attention as a promising target for cancer detection and treatments. Before EphA2 receptor-targeting antibodies or peptides are …

    fu-berlin Repository record for Expression patterns of EphA2 tyrosine kinase receptor in human digestive system organs and tumors (opens in a new tab)

  14. An investigation into the role of Rab-Coupling Protein and EphA2 during cancer cell migration

    … MALDI-TOF mass spectrometry, I have identified EphA2 and two Rab GTPases, Rab6 and Rab14, as novel RCP-associated proteins. Immunoprecipitation-based studies confirm these associations using several different cancer cell lines. EphA2 is a receptor tyrosine kinase (RTK) that is required for …

    glasgow Download PDF for An investigation into the role of Rab-Coupling Protein and EphA2 during cancer cell migration (opens in a new tab)

  15. Proteomics uncover EPHA2 in cetuximab resistant colorectal cancer cell lines as a potential novel therapeutic target

    … proteomics identified Ephrin type-A receptor 2 (EPHA2) overexpression as a common feature in all CET resistant cell lines. These resistant cells displayed significantly stronger migration than their parental counterparts (p<0,01) and EPHA2 was found to be a molecular driver of cell migration. …

    lmu-germany Repository record for Proteomics uncover EPHA2 in cetuximab resistant colorectal cancer cell lines as a potential novel therapeutic target (opens in a new tab)

  16. Development of antibody fragment-based radiotheranostic agents for cancer

    … the use of copper-64 (64Cu) radiolabeled anti-EphA2 minibody for pre-treatment diagnosis of antigen expression via Positron Emission Tomography (PET). Minibodies (VH, VL and CH3) are advantageous for use as targeting molecules over intact antibodies (IgG) due to accelerated serum clearance …

    missouri Repository record for Development of antibody fragment-based radiotheranostic agents for cancer (opens in a new tab)

  17. Epidermal Growth Factor Receptor and Eph Receptor A2: Understanding mechanisms of activation and therapeutic resistance of receptor tyrosine kinases

    … (EGFR) and the Eph family type A2 receptor (EphA2). Individually, these RTKs are interesting therapeutic targets, but there is also evidence that the interaction between these proteins is responsible the development of tumor resistance to EGFR-targeting therapies. We first develop a novel …

    utk-theses Repository record for Epidermal Growth Factor Receptor and Eph Receptor A2: Understanding mechanisms of activation and therapeutic resistance of receptor tyrosine kinases (opens in a new tab)

  18. EXPLORING THE CROSSTALK BETWEEN POLO-LIKE KINASE 1 AND Eph-FAMILY OF RECEPTORS IN CELL DIVISION IN PANCREATIC CANCER MODEL

    … behaviour. Of the majority of Eph receptors EphA2 is overexpressed in many cancers and in PDAC as well. A wealth of literature has reported an increased expression of PLK1 but therapeutic targeting has not been beneficial and hence an alternative strategies are required to treat PDAC …

    sask Repository record for EXPLORING THE CROSSTALK BETWEEN POLO-LIKE KINASE 1 AND Eph-FAMILY OF RECEPTORS IN CELL DIVISION IN PANCREATIC CANCER MODEL (opens in a new tab) Embargoed until 2026-12-11

Page 1 of 4